Citizens Financial Group Inc Novartis Ag Transaction History

Citizens Financial Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $167,976 - $186,095	-2,045 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $5,422 - $6,103	-67 Reduced 3.17%	2,045 $179,000
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $8,268 - $11,584	-117 Reduced 5.25%	2,112 $174,000
Q4 2019 Feb 07, 2020	BUY	$84.35 - $95.37 $3,374 - $3,814	40 Added 1.83%	2,229 $211,000
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $7,356 - $8,106	-86 Reduced 3.78%	2,189 $190,000

Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $3,242 - $3,990	-43 Reduced 1.86%	2,275 $208,000
Q1 2019 May 09, 2019	BUY	$75.32 - $86.15 $11,523 - $13,180	153 Added 7.07%	2,318 $223,000
Q4 2018 Feb 11, 2019	SELL	$73.66 - $82.02 $3,683 - $4,101	-50 Reduced 2.26%	2,165 $185,000
Q2 2018 Jul 27, 2018	SELL	$64.91 - $73.36 $714 - $806	-11 Reduced 0.49%	2,215 $168,000
Q1 2018 May 11, 2018	BUY	$70.39 - $84.15 $2,322 - $2,776	33 Added 1.5%	2,226 $180,000
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $8,534 - $9,161	-118 Reduced 5.11%	2,193 $184,000
Q3 2017 Nov 13, 2017	SELL	$74.14 - $77.27 $6,820 - $7,108	-92 Reduced 3.83%	2,311 $199,000
Q2 2017 Aug 10, 2017	BUY	N/A	2,403	2,403 $200,000

1,346

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.